JOHN PAUL KELADA: Open Payments
NPI 1013396118 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,539 in 115 payments from 35 companies in 2025. Trend: 2023 $2,496 · 2024 $2,572 · 2025 $2,539
Food & beverage: $2,539
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $235 |
| ABBVIE INC. | 10 | $197 |
| Novo Nordisk Inc | 9 | $193 |
| Exact Sciences Corporation | 8 | $185 |
| GlaxoSmithKline, LLC. | 10 | $181 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $165 |
| Lilly USA, LLC | 8 | $155 |
| Corcept Therapeutics | 5 | $123 |
| ViiV Healthcare Company | 3 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
Products named: Kerendia, Korlym, TRELEGY ELLIPTA, JARDIANCE, NURTEC ODT, Rybelsus, APRETUDE, MOUNJARO.
Industry payments across CA — which companies pay providers there.
